UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Elucidation of Novel Molecular Targets for Therapeutic Strategies in Urothelial Carcinoma: A Literature Review

Frontiers in oncology, 2021-08, Vol.11, p.705294-705294

2021

Volltextzugriff (PDF)

Diffuse Large B-Cell Lymphoma with Aberrant Coexpression of CD5 and CD8 T-Cell Markers

Case reports in oncology, 2024-01, Vol.17 (1), p.517-523

2024

Volltextzugriff (PDF)

Novel Molecular Targets for the Therapy of Urothelial Cancer

Anticancer research, 2015-09, Vol.35 (9), p.4557-4567

2015

Volltextzugriff (PDF)

Vascular stenting of a malignant arterial blowout as a bridge to effective systemic and regional therapy

Journal of surgical oncology, 2024-06, Vol.129 (7), p.1209-1212

2024

Volltextzugriff (PDF)

Iron Overload in an HFE Heterozygous Carrier: A Case Report and Literature Review

Laboratory medicine, 2019-04, Vol.50 (2), p.212-217

2019

Volltextzugriff (PDF)

Standard-Dose Rituximab as Effective Therapy for Treating Malignancy-Related Hemophagocytic Lymphohistiocytosis in the Eldery: A Case Report

Case reports in oncology, 2021-07, Vol.14 (2), p.1066-1070

2021

Volltextzugriff (PDF)

Nivolumab-Induced, Late-Onset, Steroid-Sensitive, High-Grade Pneumonitis and Durable Tumor Suppression in Metastatic Renal Cell Carcinoma: A Case Report

Case reports in oncological medicine, 2019-12, Vol.2019, p.6759472-5

2019

Volltextzugriff (PDF)

A unique case of hemolytic‐uremic syndrome secondary to enteropathogenic E Coli

Clinical case reports, 2020-12, Vol.8 (12), p.2625-2628

2020

Volltextzugriff (PDF)

Novel molecular targets for the therapy of urothelial carcinoma

Expert opinion on therapeutic targets, 2012-05, Vol.16 (5), p.499-513

2012

Volltextzugriff (PDF)

Septic Shock Predisposed by an Underlying Chronic Neutrophilic Leukemia with an Atypical Presentation; A Case Report

Case reports in oncology, 2018-12, Vol.11 (3), p.871-879

2018

Volltextzugriff (PDF)

Angioedema with normal C1q and C1 inhibitor: an atypical presentation of Waldenström macroglobulinemia

International journal of hematology, 2013-05, Vol.97 (5), p.654-656

2013

Volltextzugriff (PDF)

Durable Hematological and Major Cytogenetic Response in a Patient with Isolated 20q Deletion Myelodysplastic Syndrome Treated with Lenalidomide

Case reports in oncological medicine, 2014-01, Vol.2014, p.949515-4

2014

Volltextzugriff (PDF)

Alternative Therapy for Epstein-Barr Virus Related Hemophagocytic Lymphohistiocytosis

Case reports in oncological medicine, 2015-01, Vol.2015, p.508387-3

2015

Volltextzugriff (PDF)

Concordance and discordance in myeloma bone marrow studies

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e19508-e19508

2019

Volltextzugriff (PDF)

Concordance and Discordance in Myeloma Bone Marrow Studies

Clinical lymphoma, myeloma and leukemia, 2019-09, Vol.19, p.S321-S322

2019

Volltextzugriff (PDF)

A phase II study of nivolumab with ipilimumab and cabozantinib in patients with untreated renal cell carcinoma brain metastases

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.TPS745-TPS745

2023

Volltextzugriff (PDF)

A Case of Philadelphia Chromosome Positive Myeloproliferative Neoplasm in a Pregnant Woman with Unusual Primary Myelofibrosis Features

Case reports in hematology, 2013-01, Vol.2013, p.702831-4

2013

Volltextzugriff (PDF)

A phase II trial modifying metabolic syndrome and cardiovascular risk for patients with prostate cancer on ADT using a risk factor modification program and continuous Fitbit monitoring (ProTrio)

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.TPS273-TPS273

2023

Volltextzugriff (PDF)

Phase II Clinical and Translational Study of Everolimus ± Paclitaxel as First-Line Therapy in Cisplatin-Ineligible Advanced Urothelial Carcinoma

The oncologist (Dayton, Ohio), 2022-06, Vol.27 (6), p.432-e452

2022

Volltextzugriff (PDF)

OCTS-06 A PHASE II STUDY OF NIVOLUMAB WITH IPILIMUMAB AND CABOZANTINIB IN PATIENTS WITH UNTREATED RENAL CELL CARCINOMA BRAIN METASTASES

Neuro-oncology advances, 2024-08, Vol.6 (Supplement_1), p.i27-i28

2024

Volltextzugriff (PDF)

Discerning Patterns and Quality of Neoadjuvant Chemotherapy Use Among Patients with Muscle-invasive Bladder Cancer

European urology oncology, 2019-09, Vol.2 (5), p.497-504

2019

Volltextzugriff (PDF)

Angioedema with normal Clq and C1 inhibitor: an atypical presentation of Waldenstrom macroglobulinemia

International journal of hematology, 2013, Vol.97 (5), p.654-656

2013

Volltextzugriff (PDF)

Multimodality treatment of locally advanced penile cancer: A contemporary dosimetric comparison and case presentation

Journal of clinical oncology, 2012-02, Vol.30 (5_suppl), p.346-346

2012

Volltextzugriff (PDF)

Diffuse Large B-Cell Lymphoma with Aberrant Coexpression of CD5 and CD8 T-Cell Markers

Case reports in oncology, 2024, Vol.17 (1), p.517-523

2024

Volltextzugriff (PDF)

Standard-Dose Rituximab as Effective Therapy for Treating Malignancy-Related Hemophagocytic Lymphohistiocytosis in the Eldery: A Case Report

Case reports in oncology, 2021, Vol.14 (2), p.1066-1070

2021

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(25)
Berichte
(4)

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(17)
Science & Technology
(17)
Oncology
(12)
Case Report
(9)
Humans
(7)
Case Reports
(6)
Patients
(5)
Aged
(3)
Biopsy
(3)
Bone Marrow
(3)
Carcinoma, Transitional Cell - Drug Therapy
(3)
Development And Progression
(3)
Drug Therapy
(3)
Female
(3)
Hematology
(3)
Immunotherapy
(3)
Infections
(3)
Middle Aged
(3)
Monoclonal Antibodies
(3)
Mutation
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Elucidation of Novel Molecular Targets for Therapeutic Strategies in Urothelial Carcinoma: A Literature Review

Diffuse Large B-Cell Lymphoma with Aberrant Coexpression of CD5 and CD8 T-Cell Markers

Novel Molecular Targets for the Therapy of Urothelial Cancer

Vascular stenting of a malignant arterial blowout as a bridge to effective systemic and regional therapy

Iron Overload in an HFE Heterozygous Carrier: A Case Report and Literature Review

Standard-Dose Rituximab as Effective Therapy for Treating Malignancy-Related Hemophagocytic Lymphohistiocytosis in the Eldery: A Case Report

Nivolumab-Induced, Late-Onset, Steroid-Sensitive, High-Grade Pneumonitis and Durable Tumor Suppression in Metastatic Renal Cell Carcinoma: A Case Report

A unique case of hemolytic‐uremic syndrome secondary to enteropathogenic E Coli

Novel molecular targets for the therapy of urothelial carcinoma

Septic Shock Predisposed by an Underlying Chronic Neutrophilic Leukemia with an Atypical Presentation; A Case Report

Angioedema with normal C1q and C1 inhibitor: an atypical presentation of Waldenström macroglobulinemia

Durable Hematological and Major Cytogenetic Response in a Patient with Isolated 20q Deletion Myelodysplastic Syndrome Treated with Lenalidomide

Alternative Therapy for Epstein-Barr Virus Related Hemophagocytic Lymphohistiocytosis

Concordance and discordance in myeloma bone marrow studies

Concordance and Discordance in Myeloma Bone Marrow Studies

A phase II study of nivolumab with ipilimumab and cabozantinib in patients with untreated renal cell carcinoma brain metastases

A Case of Philadelphia Chromosome Positive Myeloproliferative Neoplasm in a Pregnant Woman with Unusual Primary Myelofibrosis Features

A phase II trial modifying metabolic syndrome and cardiovascular risk for patients with prostate cancer on ADT using a risk factor modification program and continuous Fitbit monitoring (ProTrio)

Phase II Clinical and Translational Study of Everolimus ± Paclitaxel as First-Line Therapy in Cisplatin-Ineligible Advanced Urothelial Carcinoma

OCTS-06 A PHASE II STUDY OF NIVOLUMAB WITH IPILIMUMAB AND CABOZANTINIB IN PATIENTS WITH UNTREATED RENAL CELL CARCINOMA BRAIN METASTASES

Discerning Patterns and Quality of Neoadjuvant Chemotherapy Use Among Patients with Muscle-invasive Bladder Cancer

Angioedema with normal Clq and C1 inhibitor: an atypical presentation of Waldenstrom macroglobulinemia

Multimodality treatment of locally advanced penile cancer: A contemporary dosimetric comparison and case presentation

Diffuse Large B-Cell Lymphoma with Aberrant Coexpression of CD5 and CD8 T-Cell Markers

Standard-Dose Rituximab as Effective Therapy for Treating Malignancy-Related Hemophagocytic Lymphohistiocytosis in the Eldery: A Case Report

Suchergebnisse filtern